TC
PFE icon

Tatro Capital’s Pfizer PFE Stock Holding History

Tatro Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.25M Buy
24,077
+1,196
+5% +$62.1K 0.93% 23
2021
Q4 		$1.35M Buy
22,881
+303
+1% +$15K 0.97% 24
2021
Q3 		$971K Sell
22,578
-69
-0.3% -$3.06K 0.76% 25
2021
Q2 		$887K Buy
22,647
+2,642
+13% +$103K 0.61% 30
2021
Q1 		$725K Buy
20,005
+9,370
+88% +$333K 0.56% 34
2020
Q4 		$391K Buy
10,635
+4,083
+62% +$150K 0.36% 46
2020
Q3 		$228K Sell
6,552
-166
-2% -$5.82K 0.26% 57
2020
Q2 		$208K Sell
6,718
-82
-1% -$2.79K 0.3% 52
2020
Q1 		$211K Sell
6,800
-886
-12% -$30.2K 0.38% 39
2019
Q4 		$286K Buy
+7,686
New +$274K 0.26% 39

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Tatro Capital's PFE Position: Q1 2022 in Review

Tatro Capital increased its Pfizer (PFE) stake by 5.2% in Q1 2022, buying an estimated $62.1K and bringing the position to 24,077 shares worth $1.25M. The position accounts for 0.93% of the portfolio, ranked #23.

Tatro Capital first reported a position in PFE in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.35M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Tatro Capital held 24,077 shares of Pfizer worth $1.25M as of Q1 2022.
  • Tatro Capital bought 1,196 Pfizer shares in Q1 2022, an estimated $62.1K.
  • Pfizer made up 0.93% of Tatro Capital's portfolio in Q1 2022, its #23 holding.
  • Tatro Capital first reported a position in Pfizer in Q4 2019 and has held it in 10 quarters since.
  • Tatro Capital's Pfizer position peaked at $1.35M in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Tatro Capital's 13F filing for Q1 2022, filed 13 May 2022.